… cheaper version of costly Bayers’ Nexavar, it was a revolutionary moment … four lifesaving drugs. These are: breast cancer drugs Ribociclib (Rs 64,000 … it opposed compulsory licensing for breast-cancer drugs (but silent on others …

… tivozanib vs sorafenib (Nexavar), which was also inconsistent … with HER2-overexpressing breast cancer.23 Issues precluding … with HER2-overexpressing breast cancer or metastatic gastric … hziy-metastatic-triple-negative-breast-cancer FDA. Complete Response …

… secured the permit to manufacture Nexavar, a cancer drug made by … Emcure Pharmaceuticals for Trastuzumab (for breast cancer), says Sneha Sharma, a partner …

… of oncology across indications including breast cancer, ovarian cancer, nasopharyngeal carcinoma, as … choice of Lenvima (lenvatinib) or Nexavar (sorafenib) monotherapy. For those treated …

… —it could have been sorafenib [Nexavar]. What were the outcomes of … preserve ovarian function as with breast cancer treatment? It’s a great …

… receiving lenvatinib (Lenvima) or sorafenib (Nexavar; 20.6 months). The 24 … , particularly in neuro-oncology and breast cancer. The system delivers robotic-assisted …

… with mantle cell lymphoma. In breast cancer, datopotamab deruxtecan and trastuzumab deruxtecan … overall survival compared to sorafenib (Nexavar) or lenvatinib (Lenvima). The median …

… ponatinib (Iclusig), sorafenib (Nexavar), ceritinib (Zykadia), and … at leptomeningeal disease from breast cancer, lung cancer, and … We are looking at breast cancer, specifically. In our … treat patients with breast cancer and leptomeningeal disease. …

… .2-18.5) with sorafenib (Nexavar) in patients with previously untreated … , including liver, lung, gastric, and breast cancer. This agent is approved in …